Entergris

**Wednesday, October 27, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST** Freezing and thawing at scale of API and BDS biologics is not routine and should be handled with the consideration given to any critical unit operation. This webinar highlights key protein related quality challenges associated with freeze methods. Optimization thorough model freeze/thaw studies are presented.

An examination of Novel gene therapy development, understanding the biologic, the materials it contacts and intricacies of equipment, service offerings and partners to ensure effective cold-chain scale-up in cryogenic operations.

***Live: Wednesday March 17, 2021 at 11am EDT| 8am PDT| 4pm GMT| 5pm CET *** Single-use material selection is a crucial element of process development for bioprocessing, and emerging viral vector-based therapies have special requirements. Learn about efforts to better understand the relationship of single-use material selection and process impact to improve yield. ***On Demand until March 17, 2022***